Pharmacotherapy of Migraine

by Afzal, Sidra

Pharmacology

Your browser is too old

We can't provide a great video experience on old browser

Update now
Data 2fimages 2fbgpujolos9mlebqjkmv6 180919 s0 afzal sidra pharmacotherapy of migraine intro
03:55
Pharmacotherapy of Migraine
Data 2fimages 2f2wunysatrvqub502jjmb 180919 s1 afzal sidra migraine treatment
20:00
Migraine Treatment
Data 2fimages 2fg3iy8bessbgwu4egvzrg 180919 s2 afzal sidra triptans
16:17
Triptans
Data 2fimages 2foyomp7vrrrssyhvpoh00 180919 s3 afzal sidra anticonvulsants
08:19
Anticonvulsants
Data 2fimages 2fyquj2mbmqxahytixdmbk 180919 s4 afzal sidra prophylactic therapy
12:18
Prophylactic Therapy
Data 2fimages 2fgjdeca6jrskmbxedblzk 180919 s5 afzal sidra other drugs and special conditions
11:08
Other Drugs and Special Conditions

Lecture´s Description

Migraine Treatment
In this lecture ´´Pharmacotherapy of Migraine´´ is explained. Section one is about ‘‘Migraine Treatment’’. Educator begins by explaining migraine. After that, talks about history of treatment. Then reveals information about treatment. Subsequently, goals of therapy are highlighted. Later on, acute attack management is discussed. Information about analgesics is also given. Following this, antiemetics comes under consideration. Next focus is on 5-HT receptor. Moreover, antimigraine mechanism of 5-HT receptors is discussed. Then ergots are pursued. Lastly, ergotamine is highlighted.


Triptans
Section two is about ''Triptans''. Initially, educator explains triptans. In the next slide, sumatriptan is elaborated. Then its pharmacokinetics and adverse effects are reported. Likewise, naratriptan is discussed. This is followed zolmitriptan. Next, rizatriptan is focused. Later on, adverse effects of triptans are highlighted. Educator also notifies about drug interactions and contraindications. Furthermore, comparison of triptans is given. Afterwards, triptans and ergot alkaloids are elucidated. In the end, information about choosing triptan is conveyed.


Anticonvulsants
Section three is about ''Anticonvulsants''. Earlier in this section anticonvulsants are introduced. After that topiramate is discussed. Then its pharmacokinetics is pursued. This is followed by dose and adverse effects. Moreover, zonisamide is elucidated along with its adverse effects. Subsequently, levetiracetam comes under consideration. Lastly, adverse effects and contraindications are discussed by the educator.


Prophylactic Therapy
Section four is about ''Prophylactic Therapy''. In the beginning, educator tells about prophylactic therapy. Then prophylaxis is discussed. Following this, AAN/AHS guidelines are given. After that guidelines for migraine associated with menstruation are reported. Successful prophylaxis is the last subject of discussion.


Other Drugs and Special Conditions
Section five is about ''Other Drugs and Special Conditions''. Firstly, educator describes petasites. After that pregabalin is elucidated. Then candesartan is explained. Subsequently, migraine treatment in childhood and adolescents is thoroughly elaborated. Following this, quetiapine is discussed. Furthermore, migraine and pregnancy comes under consideration. Alongside, educator notify about novel drugs. Finally, vanilloid TRPV1 receptor antagonists are exhibited.

Studies have shown that V-Learning™ increases student's learning and passing rate Significantly.

Studies have shown that V-Learning™ increases student's learning and passing rate Significantly.

100% satisfaction guaranteed, join us & boost your medical Knowledge